Combined treatment with α-GalCer-loaded tumor cells and cytosine-phosphorothioate-guanine (a TLR9 agonist) in a mouse colorectal cancer model led to tumor growth inhibition and prolonged survival (Dong et al., 2016). The gene discussed is TLR9; the disease is neoplasm.